U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
101341101341Norwegian Cardio-Respiratory Arrest StudyRecruitingNo Results AvailableCardiac Arrest|Respiratory Arrest|Resuscitation|Comahttps://ClinicalTrials.gov/show/NCT01239420
101342101342Culturally-focused Consultation for Asian Americans and Latino AmericansCompletedNo Results AvailableDepressionBehavioral: Culturally focused psychiatric consultationhttps://ClinicalTrials.gov/show/NCT01239407
101343101343Ofatumumab for Initial Systemic Treatment of Indolent B-cell LymphomaActive, not recruitingNo Results AvailableFollicular Lymphoma|Marginal Zone Lymphoma|Small Lymphocytic LymphomaDrug: ofatumumabhttps://ClinicalTrials.gov/show/NCT01239394
101344101344Individualized Stereotactic Body Radiotherapy of Liver MetastasesActive, not recruitingNo Results AvailableSolid Tumor|Liver MetastasesRadiation: Stereotactic body radiotherapy-protonhttps://ClinicalTrials.gov/show/NCT01239381
101345101345Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple MyelomaRecruitingNo Results AvailableMultiple MyelomaProcedure: Adoptive Immunotherapy|Biological: Rapamycin-Generated Autologous Th1/Tc1 Cellshttps://ClinicalTrials.gov/show/NCT01239368
101346101346MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous TherapyTerminatedNo Results AvailableAdult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver CancerDrug: Akt inhibitor MK2206|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01239355
101347101347Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney CancerActive, not recruitingNo Results AvailableClear Cell Renal Cell Carcinoma|Recurrent Renal Cell Carcinoma|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer|Type 1 Papillary Renal Cell Carcinoma|Type 2 Papillary Renal Cell CarcinomaDrug: Akt Inhibitor MK2206|Drug: Everolimus|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT01239342
101348101348Malnutrition in People With Complex Multiple DisabilitiesRecruitingNo Results AvailableComplex Multiple Disabilities|Malnutritionhttps://ClinicalTrials.gov/show/NCT01239329
101349101349Vismodegib in Treating Younger Patients With Recurrent or Refractory MedulloblastomaActive, not recruitingNo Results AvailableRecurrent Childhood MedulloblastomaOther: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Vismodegibhttps://ClinicalTrials.gov/show/NCT01239316
101350101350Effects of Citrulline on Gut Functioning During ExcerciseEnrolling by invitationNo Results AvailableGastrointestinal|Hypoperfusion|Gut DamageDietary Supplement: Citrulline|Dietary Supplement: alaninehttps://ClinicalTrials.gov/show/NCT01239303
101351101351Combined Nutrient Intake and Muscle Protein SynthesisCompletedNo Results AvailableAgingOther: protein|Other: protein and carbohydrate|Other: protein and leucinehttps://ClinicalTrials.gov/show/NCT01239277
101352101352GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine TherapyTerminatedNo Results AvailableBreast CancerOther: GlowCap devicehttps://ClinicalTrials.gov/show/NCT01239251
101353101353Reduction of Asthma Exacerbation Rate in Children by Non-invasive Monitoring of Inflammatory Markers in Exhaled Breath (Condensate): the RASTER StudyCompletedNo Results AvailableAsthma|Children|Home Monitoring|Exhaled Breath Condensate|Non-invasive Inflammatory Markers|Volatile Organic Compoundshttps://ClinicalTrials.gov/show/NCT01239238
101354101354Prevalence of Abdominal Aortic Aneurysm in Patients Undergoing Coronary AngiographyCompletedNo Results AvailableCoronary AngiographyDevice: Abdominal ultra-sound|Procedure: Abdominal ultrasoundhttps://ClinicalTrials.gov/show/NCT01239225
101355101355Dosing of Levetiracetam (Keppra) in NeonatesCompletedHas ResultsSeizuresDrug: levetiracetamhttps://ClinicalTrials.gov/show/NCT01239212
101356101356Is the Exhaled Nitric Oxide in Infants a Predictive Marker of Asthma ?CompletedNo Results AvailableAsthmaOther: Measure of the exhaled NOhttps://ClinicalTrials.gov/show/NCT01239199
101357101357Identification and Characterization of the Methylation Abnormalities on Whole Genome Among Infertile MenCompletedNo Results AvailableOligospermiaOther: methylation analyses on spermatozoa from infertile menhttps://ClinicalTrials.gov/show/NCT01239186
101358101358Emotional Memory Reactivation in Posttraumatic Stress DisorderTerminatedNo Results AvailablePosttraumatic Stress DisorderDrug: AVLOCARDYL|Drug: Placebo|Drug: AVLOCARDYL|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01239173
101359101359Two Pneumatic Compression Devices in the Treatment of Lower Extremity LymphedemaRecruitingNo Results AvailableLymphedemaDevice: Flexitouch System|Device: Hydroven FPRhttps://ClinicalTrials.gov/show/NCT01239160
101360101360Effects of Whole Grain on Weight MaintenanceCompletedNo Results AvailableAbdominal Fat|Body WeightOther: Diet rich in whole grain|Other: Refined grainhttps://ClinicalTrials.gov/show/NCT01239147
101361101361Trial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid TumorsRecruitingNo Results AvailableUnresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor MalignanciesBiological: TRX518https://ClinicalTrials.gov/show/NCT01239134
101362101362Regional Data Exchange to Improve Medication SafetyActive, not recruitingNo Results AvailableDrug ToxicityOther: HIE-Enhanced Medication Reconciliationhttps://ClinicalTrials.gov/show/NCT01239121
101363101363Study of SGI-1776, a PIM Kinase Inhibitor, in Subjects With Relapsed/Refractory LeukemiasWithdrawnNo Results AvailableRelapsed/Refractory LeukemiasDrug: SGI-1776https://ClinicalTrials.gov/show/NCT01239108
101364101364Oral Green Tea Extract and Milk Thistle Extract to Colorectal Cancer Patients Undergoing ResectionRecruitingNo Results AvailableColon CancerDrug: Green Tea and Milk Thistle Supplementshttps://ClinicalTrials.gov/show/NCT01239095
101365101365Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)RecruitingNo Results AvailableColorectal CancerProcedure: Colonoscopy|Procedure: FIThttps://ClinicalTrials.gov/show/NCT01239082
101366101366Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye DiseaseCompletedNo Results AvailableDry EyeDrug: DE-110 ophthalmic suspension high dose|Drug: DE-110 ophthalmic suspension low dose|Other: Placebohttps://ClinicalTrials.gov/show/NCT01239069
101367101367Evaluation of Pancreatic Pseudocyst Drainage With a Metal StentCompletedHas ResultsPancreatic PseudocystsProcedure: Endoscopyhttps://ClinicalTrials.gov/show/NCT01239056
101368101368Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial VaccinationCompletedHas ResultsMeningitis|Meningococcal Meningitis|Meningococcal InfectionsBiological: Menomune®: A, C, Y, W 135 Meningococcal Polysaccharide|Biological: Menactra®: Meningococcal (A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugatehttps://ClinicalTrials.gov/show/NCT01239043
101369101369Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHDCompletedNo Results AvailableAttention Deficit Hyperactivity Disorder|ADHDDrug: Methylphenidate Hydrochloride Extended Release Capsuleshttps://ClinicalTrials.gov/show/NCT01239030
101370101370A Study of the Safety and Efficacy of Subcutaneously Administered REGN475 in Patients With Osteoarthritis of the KneeWithdrawnNo Results AvailableOsteoarthritisBiological: REGN475|Other: Placebohttps://ClinicalTrials.gov/show/NCT01239017

* Görseller ve İçerik tekif hakkına sahip olabilir